by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
Work that aims to bring together the results of all studies that address a particular research question. They provide a comprehensive and unbiased summary of the research. For example, one clinical trial may not give a clear answer about the effectiveness of a... by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
The probability of observing a treatment effect as large as that seen in the sample (such as in randomised controlled trial), when there is no treatment effect in the wider population, is less than 0.05. HTAI by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
The organisation that makes a submission to PBAC or MSAC or PLAC to have a health technology (such as a medicine or treatment) assessed. It is usually the manufacturer, but patient groups can be sponsors. by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
Any extra effects from a drug, treatment or procedure that are not planned, even when used as instructed. They do not necessarily cause harm. HTAI by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
An academic review of primary research studies to gain new insights on a specific topic (such as a systematic review). HTAI by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
see Special Access Scheme. by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
The government scheme which provides for the import and supply of an unapproved therapeutic good to a single patient on a case-by-case basis. by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
The study of adverse effects from treatments. HTAI